Important role of interferon regulatory factor (IRF)-3 in the interferon response of mouse macrophages upon infection by Newcastle disease virus

International Journal of Oncology

Volumn 39, Issue 2, 2011, Pages 493-504

  Wilden, Holger ^a   Schirrmacher, Volker ^a,b   Fournier, Philippe ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Center of Immunology and Oncology (IOZK)   (Germany)

Author keywords

Innate; Interferon regulatory factor 3; Interferon regulatory factor 7; Type I interferon; Virus infection and replication

Indexed keywords

INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INFECTION SENSITIVITY; INNATE IMMUNITY; MACROPHAGE; MOUSE; NEWCASTLE DISEASE; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNITY; VIRUS IMMUNITY; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ANIMALS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; INTERFERON REGULATORY FACTOR-7; INTERFERON TYPE I; INTERFERONS; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; VIRUS REPLICATION;

EID: 79959955264     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1033     Document Type: Article

References (33)

1. Klimp AH, de Vries EG, Scherphof GL and Daemen T: A potential role of macrophage activation in the treatment of cancer. Crit Rev Oncol Hematol 44: 143-161, 2002. (Pubitemid 36159043)
2. Schirrmacher V and Fournier P: Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer. Methods Mol Biol 542: 565-605, 2009.
3. Wilden H, Fournier P, Zawatzky R and Schirrmacher V: Expression of RIG-I, IRF-3, IFN-β and IRF-7 determines resistance or susceptibility of cells to infection by Newcastle disease virus. Int J Oncol 34: 971-982, 2009.
4. Schirrmacher V, Bai L, Umansky V, Yu L, Xing Y and Qian Z: Newcastle disease virus activates macrophages for anti-tumor activity. Int J Oncol 16: 363-373, 2000.
5. Umansky V, Shatrov VA, Lehmann V and Schirrmacher V: Induction of NO synthesis in macrophages by Newcastle disease virus is associated with activation of nuclear factor-kappa B. Int Immunol 8: 491-498, 1996. (Pubitemid 26115863)
6. Dunn GP, Koebel CM and Schreiber RD: Interferons, immunity and cancer immunoediting. Nat Rev Immunol 6: 836-848, 2006. (Pubitemid 44631652)
7. Ferrantini M, Capone I and Belardelli F: Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use. Biochimie 89: 884-893, 2007. (Pubitemid 47001642)
8. Moschos S, Varanasi S and Kirkwood JM: Interferons in the treatment of solid tumors. Cancer Treat Res 126: 207-241, 2005.
9. Pagès F, Lebel-Binay S, Vieillefond A, Deneux L, Cambillau M, Soubrane O, Debré B, Tardy D, Lemonne JL, Abastado JP, Fridman WH and Thiounn N: Local immunostimulation induced by intravesical administration of autologous interferon-gamma-activated macrophages in patients with superficial bladder cancer. Clin Exp Immunol 127: 303-309, 2002. (Pubitemid 34233937)
10. Thiounn N, Pages F, Mejean A, Descotes JL, Fridman WH and Romet-Lemonne JL: Adoptive immunotherapy for superficial bladder cancer with autologous macrophage activated killer cells. J Urol 168: 2373-2376, 2002. (Pubitemid 35402616)
11. Monnet I, Breau JL, Moro D, Lena H, Eymard JC, Ménard O, Vuillez JP, Chokri M, Romet-Lemonne JL and Lopez M: Intrapleural infusion of activated macrophages and gamma-interferon in malignant pleural mesothelioma: a phase II study. Chest 121: 1921-1927, 2002.
12. Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P and Mantovani A: Macrophage polarization in tumour progression. Semin Cancer Biol 18: 349-355, 2008.
13. Au WC, Moore PA, Lowther W, Juang YT and Pitha PM: Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc Natl Acad Sci USA 92: 11657-11661, 1995. (Pubitemid 26014172)
14. Izaguirre A, Barnes BJ Amrute S, Yeow WS, Megjugorac N, Dai J, Feng D, Chung E, Pitha PM and Fitzgerald-Bocarsly P: Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells. J Leukoc Biol 74: 1125-1138, 2003. (Pubitemid 38040335)
15. Kerkmann M, Rothenfusser S, Hornung V, Towarowski A, Wagner M, Sarris A, Giese T, Endres S and Hartmann G: Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J Immunol 170: 4465-4474, 2003. (Pubitemid 36519951)
16. Al-Garib SO, Gielkens AL, Gruys E, Peeters BP and Koch G: Tissue tropism in the chicken embryo of non-virulent and virulent Newcastle diseases strains that express green fluorescence protein. Avian Pathol 32: 591-596, 2003. (Pubitemid 38106431)
17. Schirrmacher V, Haas C, Bonifer R, Ahlert T, Gerhards R and Ertel C: Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus. Gene Ther 6: 63-73, 1999. (Pubitemid 29043695)
18. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N and Taniguchi T: IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777, 2005. (Pubitemid 44739521)
19. Juang YT, Lowther W, Kellum M, Au WC, Lin R, Hiscott J and Pitha PM: Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc Natl Acad Sci USA 95: 9837-9842, 1998. (Pubitemid 28415256)
20. Marie I, Durbin JE and Levy DE: Differential viral induction of distinct interferon- genes by positive feedback through interferon regulatory factor-7 EMBO J 17: 6660-6669, 1998.
21. Sato M, Hata N, Asagiri M, Nakaya T, Taniguchi T and Tanaka N Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett 441: 106-110, 1998. (Pubitemid 29012382)
22. Levy DE, Marie I, Smith E and Prakash A: Enhancement and diversification of IFN induction by IRF-7-mediated positive feedback. J Interferon Cytokine Res 22: 87-93, 2002. (Pubitemid 34161286)
23. Zhu FX, King SM, Smith EJ Levy DE and Yuan Y: A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc Natl Acad Sci USA 99: 5573-5578, 2002. (Pubitemid 34411590)
24. Lin R, Noyce RS, Collins SE, Everett RD and Mossman KL: The herpes simplex virus ICPO RING finger domain inhibits IRF-3- and IRF-7-mediated activation of interferon-stimulated genes. J Virol 78: 1675-1684, 2004. (Pubitemid 38176700)
25. Barro M and Patton JT: Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF-3, IRF5 and IRF-7. J Virol 81: 4473-4481, 2007. (Pubitemid 46668645)
26. Yu Y, Wang SE and Hayward GS: The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF-7 for proteosome-mediated degradation. Immunity 22: 59-70, 2005. (Pubitemid 40143451)
27. Lu R, Au WC, Yeow WS, Hageman N and Pitha PM: Regulation of the promoter activity of interferon regulatory factor-7 gene. Activation by interferon and silencing by hypermethylation. J Biol Chem 275: 31805-31812, 2000.
28. Ning S, Huye LE and Pagano JS: Regulation of the transcriptional activity of the IRF-7 promoter by a pathway independent of interferon signaling. J Biol Chem 280: 12262-12270, 2005.
29. Maniatis T, Falvo JV, Kim TH, Kim TK, Lin CH, Parekh BS and Wathelet MG: Structure and function of the interferon-beta enhanceosome. Cold Spring Harb Symp Quant Biol 63: 609-620, 1998.
30. Hayakawa S, Shiratori S, Yamato H, Kameyama T, Kitatsuji C, Kashigi F, Goto S, Kameoka S, Fujikura D, Yamada T, Mizutani T, Kazumata M, Sato M, Tanaka J, Asaka M, Ohba Y, Miyazaki T, Imamura M and Takaoka A: ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses. Nat Immunol 12: 37-44, 2011.
31. Steinberg C, Eisenächer K, Gross O, Reindl W, Schmitz F, Ruland J and Krug A: The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection. Eur J Immunol 39: 1007-1018, 2009.
32. Barnes BJ, Richards J Mancl M, Hanash S, Beretta L and Pitha PM: Global and distinct targets of IRF 5 and IRF-7 during innate response to viral infection. J Biol Chem 279: 45194-45207, 2004. (Pubitemid 39430935)
33. Romieu-Mourez R, Solis M, Nardin A, Goubau D, Baron-Bodo V, Lin R, Massie B, Salcedo M and Hiscott J: Distinct roles for IFN regulatory factor (IRF)-3 and IRF-7 in the activation of antitumor properties of human macrophages. Cancer Res 66: 10576-10585, 2006. (Pubitemid 44799781)